Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Capital Expenditures (2020 - 2025)

Biomea Fusion (BMEA) posted Capital Expenditures of -$619000.0 for Q4 2025, up 88.01% sequentially from -$5.2 million in Q4 2024, and up 88.01% YoY from -$329232.3 in Q4 2024.

Biomea Fusion (BMEA) Capital Expenditures (2020 - 2025) Analysis & Trends

Biomea Fusion has reported Capital Expenditures for 6 years, with the latest figure at -$619000.0 in Q4 2025.

  • Quarterly Capital Expenditures rose 88.01% year-over-year to -$619000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$619000.0 (up 87.33% YoY) and the FY2025 annual result came in at -$619000.0, up 87.33% from the prior year.
  • Capital Expenditures grew to -$619000.0 in Q4 2025 per BMEA's latest filing, from -$5.2 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $2.9 million in Q1 2023 and troughed at -$5.2 million in Q4 2024.
  • A 5-year average of $62117.6 and a median of $95000.0 in 2022 frame the typical range for Capital Expenditures.
  • The sharpest annual moves came in 2023 and 2024: Capital Expenditures soared 2958.95% in 2023, then slumped 414.34% in 2024.
  • Over 5 years, Capital Expenditures stood at $293000.0 in 2021, then jumped by 143.0% to $712000.0 in 2022, then tumbled by 241.01% to -$1.0 million in 2023, then plunged by 414.34% to -$5.2 million in 2024, then jumped by 88.01% to -$619000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$619000.0, -$5.2 million, and $186000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 25.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 34.68 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -73.57 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.26 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 251.02 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -619,000.00
Dec 31, 2025 -619,000.00
Dec 31, 2024 -5.16 Mn
Dec 31, 2024 -5.16 Mn
Sep 30, 2024 186,000.00
Sep 30, 2024 186,000.00
Jun 30, 2024 59,000.00
Jun 30, 2024 59,000.00
Mar 31, 2024 35,000.00
Mar 31, 2024 35,000.00
Dec 31, 2023 -1.00 Mn
Dec 31, 2023 -1.00 Mn
Sep 30, 2023 39,000.00
Sep 30, 2023 39,000.00
Jun 30, 2023 417,000.00
Jun 30, 2023 417,000.00
Mar 31, 2023 2.91 Mn
Mar 31, 2023 2.91 Mn
Dec 31, 2022 712,000.00
Dec 31, 2022 712,000.00